1. Home
  2. FMS vs ARCC Comparison

FMS vs ARCC Comparison

Compare FMS & ARCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$24.31

Market Cap

13.6B

Sector

Health Care

ML Signal

HOLD

Logo Ares Capital Corporation

ARCC

Ares Capital Corporation

HOLD

Current Price

$19.88

Market Cap

13.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMS
ARCC
Founded
1996
2004
Country
Germany
United States
Employees
108165
N/A
Industry
Misc Health and Biotechnology Services
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
13.6B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
FMS
ARCC
Price
$24.31
$19.88
Analyst Decision
Sell
Buy
Analyst Count
2
11
Target Price
$30.00
$21.36
AVG Volume (30 Days)
746.3K
4.5M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
2.57%
10.28%
EPS Growth
N/A
N/A
EPS
N/A
0.13
Revenue
N/A
N/A
Revenue This Year
N/A
$5.77
Revenue Next Year
$3.83
$2.29
P/E Ratio
$15.62
$153.92
Revenue Growth
N/A
N/A
52 Week Low
$20.02
$17.40
52 Week High
$27.64
$22.76

Technical Indicators

Market Signals
Indicator
FMS
ARCC
Relative Strength Index (RSI) 51.02 65.49
Support Level $23.55 $19.82
Resistance Level $24.63 $20.11
Average True Range (ATR) 0.50 0.33
MACD -0.14 0.11
Stochastic Oscillator 29.28 90.82

Price Performance

Historical Comparison
FMS
ARCC

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

Share on Social Networks: